080 Modulation of the T helper and T follicular helper cell distribution in pemphigus patients by B cell-depleting therapy
Farzan Solimani(Humboldt-Universität zu Berlin), Christian Möbs(Philipps University of Marburg), Michael Hertl(Universitätsklinikum Gießen und Marburg), Dario Didona(Istituto Dermopatico dell'Immacolata), Christel Baum, Kamran Ghoreschi(National Institutes of Health), Robert Pollmann(Philipps University of Marburg), Rüdiger Eming(Philipps University of Marburg), Wolfgang Pfützner(Philipps University of Marburg), Julia Holstein(University of Tübingen)
Cited by 0
Related Papers
Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
|The Journal of Immunology|2011|634
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|597
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|384
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|379
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332